Comparison of cefixime and amoxicillin plus metronidazole in the treatment of chronic periodontitis

被引:9
|
作者
Dukic, Smiljka [1 ]
Matijevic, Stevo [2 ,4 ]
Dakovic, Dragana [1 ,4 ]
Cutovic, Tatjana [3 ,4 ]
机构
[1] Mil Med Acad, Dept Periodontol & Oral Med, Crnotravska 17, Belgrade 11000, Serbia
[2] Mil Med Acad, Dept Oral Surg, Crnotravska 17, Belgrade 11000, Serbia
[3] Mil Med Acad, Dept Orthodont, Clin Dent, Crnotravska 17, Belgrade 11000, Serbia
[4] Univ Def, Mil Med Acad, Fac Med, Belgrade, Serbia
关键词
periodontal diseases; cephalosporins; amoxicillin; metronidazole; treatment outcome; GENERALIZED AGGRESSIVE PERIODONTITIS; THERAPY;
D O I
10.2298/VSP150326133D
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aim. Despite significant advances in current medicine and improvement of overall health education, chronic periodontitis is still a widespread disease. Losing teeth is the most serious complication of this particular illness. The aim of this study was to examine patients with chronic periodontitis in order to evaluate the efficacy of non-surgical therapy and combination of amoxicillin and metronidazole compared with cefixime, which has not been so far used for the treatment of this disease. Methods. Adult patients with chronic periodontitis (n = 90) underwent non-surgical periodontal treatment (zero-day) and then randomly divided into three groups. The group I served as a control, the group II was additionally treated with the combination of amoxicillin and metronidazole (for 7 days), while the group III was treated with cefixime (also for 7 days). To assess the condition of periodontium before and seven days after the therapy, four clinical parameters were used: gingival index (GI), bleeding on probing (BOP), probing depth (PD) and clinical attachment level (CAL). Results. On the day 7 after the beginning of the therapy, we found that all the three groups of patients had statistically significant clinical improvement of three parameters: GI, BOP and PD, but not of the CAL. However, the improvement of PD was only statistically, but not clinically significant. The improvement in the control group of patients on the day 7 was 19% in BOP and 28% in GI; this improvement was statistically highly significant after the addition of amoxicillin plus metronodazole (71% in BOP and 77% in GI) or cefixime (62% in BOP and 82% in GI). Compared to the combination of amoxicillin and metronidazole, cefixim was statistically significantly more effective for GI < 0.05), while for the other three clinical parameters their effects were equal. Conclusion. The conjunction of amoxicillin plus metronidazole or cefixime to the causal treatment of patients with chronic periodontitis led to statistically significant improvement in efficacy in relation to GI and BOP parameters, while cefixime was statistically significantly more efficient than the combination of amoxicillin and metronidazole for GI.
引用
收藏
页码:526 / 530
页数:5
相关论文
共 50 条
  • [31] The effect of metronidazole plus amoxicillin or metronidazole plus penicillin V on periodontal pathogens in an in vitro biofilm model
    Dabija-Wolter, Gabriela
    Al-Zubaydi, Sundus Saad
    Mohammed, Marwan Mansoor Ali
    Bakken, Vidar
    Bolstad, Anne Isine
    CLINICAL AND EXPERIMENTAL DENTAL RESEARCH, 2018, 4 (01): : 6 - 12
  • [32] Efficacy of Amoxicillin and Metronidazole Combination far the Management of Generalized Aggressive Periodontitis
    Yek, Emine Cifcibasi
    Cintan, Serdar
    Topcuoglu, Nursen
    Kulekci, Guven
    Issever, Halim
    Kantarci, Alpdogan
    JOURNAL OF PERIODONTOLOGY, 2010, 81 (07) : 964 - 974
  • [33] Microbiome changes in young periodontitis patients treated with adjunctive metronidazole and amoxicillin
    Feres, Magda
    Retamal-Valdes, Belen
    Fermiano, Daiane
    Faveri, Marcelo
    Figueiredo, Luciene Cristina
    Mayer, Marcia
    Lee, Jung-Jin
    Bittinger, Kyle
    Teles, Flavia
    JOURNAL OF PERIODONTOLOGY, 2021, 92 (04) : 467 - 478
  • [34] Treatment of Chronic Periodontitis May Be Improved by the Adjunctive Use of Systemic Metronidazole
    Faveri, Marcelo
    Figueiredo, Luciene Cristina
    Feres, Magda
    JOURNAL OF EVIDENCE-BASED DENTAL PRACTICE, 2014, 14 (02) : 70 - 72
  • [35] Moxifloxacin versus amoxicillin plus metronidazole as adjunctive therapy for generalized aggressive periodontitis: a pilot randomized controlled clinical trial
    Ardila, Carlos M.
    Florez-Florez, Juliana
    Castaneda-Parra, Luis-David
    Guzman, Isabel C.
    Bedoya-Garcia, Jader A.
    QUINTESSENCE INTERNATIONAL, 2020, 51 (08): : 612 - 621
  • [36] Six-month results following treatment of aggressive periodontitis with antimicrobial photodynamic therapy or amoxicillin and metronidazole
    Arweiler, Nicole Birgit
    Pietruska, Malgorzata
    Pietruski, Jan
    Skurska, Ana
    Dolinska, Eva
    Heumann, Christian
    Auschill, Thorsten Mathias
    Sculean, Anton
    CLINICAL ORAL INVESTIGATIONS, 2014, 18 (09) : 2129 - 2135
  • [37] Amoxicillin Plus Metronidazole Therapy for Patients with Periodontitis and Type 2 Diabetes: A 2-year Randomized Controlled Trial
    Tamashiro, N. S.
    Duarte, P. M.
    Miranda, T. S.
    Maciel, S. S.
    Figueiredo, L. C.
    Faveri, M.
    Feres, M.
    JOURNAL OF DENTAL RESEARCH, 2016, 95 (07) : 829 - 836
  • [38] Systemic moxifloxacin vs amoxicillin/metronidazole adjunct to non-surgical treatment in generalized aggressive periodontitis
    Guzeldemir-Akcakanat, Esra
    Gurgan, Cem-Abdulkadir
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2015, 20 (04): : E441 - E449
  • [39] Six-month results following treatment of aggressive periodontitis with antimicrobial photodynamic therapy or amoxicillin and metronidazole
    Nicole Birgit Arweiler
    Malgorzata Pietruska
    Jan Pietruski
    Ana Skurska
    Eva Dolińska
    Christian Heumann
    Thorsten Mathias Auschill
    Anton Sculean
    Clinical Oral Investigations, 2014, 18 : 2129 - 2135
  • [40] SINGLE-DOSE ORAL CEFIXIME VERSUS AMOXICILLIN PLUS PROBENECID FOR THE TREATMENT OF UNCOMPLICATED GONORRHEA IN MEN
    MEGRAN, DW
    LEFEBVRE, K
    WILLETTS, V
    BOWIE, WR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (02) : 355 - 357